Balancing diuretic therapy in heart failure: Loop diuretics, thiazides, and aldosterone antagonists

22Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In heart failure, sodium is retained by the kidneys despite increases in extracellular volume. There is activation of renin secretion, which culminates in the production of angiotensin II, causing vasoconstriction and aldosterone secretion. These synergistically produce an increase in tubular reabsorption of sodium and water. Diuretics are the mainstay of symptomatic treatment to remove excess extracellular fluid in heart failure. Diuretics that affect the ascending loop of Henle are most commonly used. Thiazide diuretics promote a much greater natriuretic effect when combined with a loop diuretic in patients with refractory edema. Recently, spironolactone, an aldosterone receptor blocking agent, has been recommended to attenuate some of the neurohormonal effects of heart failure. Regardless of the diuretic, patients need to be counseled on the importance of avoiding sodium in their diet. © 2002 CHF, Inc.

Cite

CITATION STYLE

APA

Paul, S. (2002). Balancing diuretic therapy in heart failure: Loop diuretics, thiazides, and aldosterone antagonists. Congestive Heart Failure. CHF Inc. https://doi.org/10.1111/j.1527-5299.2002.00700.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free